Seer Inc (SEER) - Total Liabilities
Based on the latest financial reports, Seer Inc (SEER) has total liabilities worth $30.96 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Seer Inc to see how much of total assets are deployed in long-term investments.
Seer Inc - Total Liabilities Trend (2018–2025)
This chart illustrates how Seer Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Seer Inc asset portfolio.
Seer Inc Competitors by Total Liabilities
The table below lists competitors of Seer Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
UBcare. Co. Ltd
KQ:032620
|
Korea | ₩73.17 Billion |
|
Bogota Financial Corp
NASDAQ:BSBK
|
USA | $785.12 Million |
|
Protech Mitra Perkasa Tbk PT
JK:OASA
|
Indonesia | Rp78.88 Billion |
|
PT Buana Artha Anugerah Tbk
JK:STAR
|
Indonesia | Rp28.36 Billion |
|
icad inc
NASDAQ:ICAD
|
USA | $8.68 Million |
|
Yi Jinn Industrial Co Ltd
TW:1457
|
Taiwan | NT$8.31 Billion |
|
Yoosung T&S Co. Ltd
KQ:024800
|
Korea | ₩99.40 Billion |
|
Zeotech Ltd
AU:ZEO
|
Australia | AU$1.12 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Seer Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Seer Inc's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 14.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Seer Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Seer Inc (2018–2025)
The table below shows the annual total liabilities of Seer Inc from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $36.78 Million | -5.77% |
| 2024-12-31 | $39.03 Million | -0.86% |
| 2023-12-31 | $39.37 Million | -3.84% |
| 2022-12-31 | $40.94 Million | +13.01% |
| 2021-12-31 | $36.22 Million | +238.22% |
| 2020-12-31 | $10.71 Million | +92.73% |
| 2019-12-31 | $5.56 Million | +49.34% |
| 2018-12-31 | $3.72 Million | -- |
About Seer Inc
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis … Read more